2016 Q4 Form 10-Q Financial Statement

#000104396116000037 Filed on November 14, 2016

View on sec.gov

Income Statement

Concept 2016 Q4 2016 Q3 2015 Q3
Revenue $360.0K $445.0K $330.0K
YoY Change -12.2% 34.85% -91.88%
Cost Of Revenue $290.0K $231.0K $445.0K
YoY Change -49.12% -48.09% -81.04%
Gross Profit $70.00K $134.0K -$115.0K
YoY Change -143.75% -216.52% -106.7%
Gross Profit Margin 19.44% 30.11% -34.85%
Selling, General & Admin $1.800M $497.0K $1.686M
YoY Change 8.43% -70.52% -66.7%
% of Gross Profit 2571.43% 370.9%
Research & Development $360.0K $393.0K $455.0K
YoY Change -25.0% -13.63% -29.02%
% of Gross Profit 514.29% 293.28%
Depreciation & Amortization $160.0K $100.0K $100.0K
YoY Change 6.67% 0.0% -83.02%
% of Gross Profit 228.57% 74.63%
Operating Expenses $2.150M $497.0K $2.141M
YoY Change 0.47% -76.79% -62.46%
Operating Profit -$2.080M -$363.0K -$2.256M
YoY Change -9.57% -83.91% -43.42%
Interest Expense $180.0K -$140.0K $210.0K
YoY Change -151.43% -166.67% -200.0%
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00 -$6.000K
YoY Change -100.0% -100.0% 500.0%
Pretax Income -$2.110M -$499.0K -$2.051M
YoY Change -20.08% -75.67% -51.17%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$1.430M -$499.0K -$7.299M
YoY Change -92.61% -93.16% 9023.75%
Net Earnings / Revenue -397.22% -112.13% -2211.82%
Basic Earnings Per Share
Diluted Earnings Per Share -$23.83M -$16.67M -$243.3M
COMMON SHARES
Basic Shares Outstanding 24.79M shares 23.55M shares 13.87M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q4 2016 Q3 2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $50.00K $70.00K $2.790M
YoY Change -88.64% -97.49% 217.05%
Cash & Equivalents $51.00K $68.00K $2.787M
Short-Term Investments
Other Short-Term Assets $13.00K $314.0K $534.0K
YoY Change -97.58% -41.2% -68.84%
Inventory $100.0K $36.00K
Prepaid Expenses $100.0K $100.0K
Receivables $388.0K $180.0K $9.252M
Other Receivables $0.00 $200.0K $0.00
Total Short-Term Assets $552.0K $866.0K $16.10M
YoY Change -83.18% -94.62% 17.63%
LONG-TERM ASSETS
Property, Plant & Equipment $280.0K $172.0K $303.0K
YoY Change 8.11% -43.23% -81.66%
Goodwill $6.918M
YoY Change 0.0%
Intangibles $0.00 $982.0K $1.000M
YoY Change -100.0% -1.8% -87.97%
Long-Term Investments
YoY Change
Other Assets $10.00K $58.00K $125.0K
YoY Change -90.48% -53.6% -54.71%
Total Long-Term Assets $290.0K $1.212M $8.346M
YoY Change -81.1% -85.48% -51.36%
TOTAL ASSETS
Total Short-Term Assets $552.0K $866.0K $16.10M
Total Long-Term Assets $290.0K $1.212M $8.346M
Total Assets $842.0K $2.078M $24.45M
YoY Change -82.52% -91.5% -20.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.084M $6.273M $3.732M
YoY Change -71.33% 68.09% 10.45%
Accrued Expenses $700.0K $2.704M $2.368M
YoY Change -81.25% 14.19% 20.82%
Deferred Revenue
YoY Change
Short-Term Debt $700.0K $0.00 $0.00
YoY Change
Long-Term Debt Due $395.0K $7.814M $6.275M
YoY Change -94.8% 24.53% 353.72%
Total Short-Term Liabilities $3.012M $18.26M $16.15M
YoY Change -82.26% 13.09% 64.6%
LONG-TERM LIABILITIES
Long-Term Debt $4.127M $0.00 $525.0K
YoY Change -100.0% -90.64%
Other Long-Term Liabilities $0.00 $212.0K $886.0K
YoY Change -100.0% -76.07% -55.0%
Total Long-Term Liabilities $4.127M $212.0K $1.411M
YoY Change 1253.11% -84.98% -81.39%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.012M $18.26M $16.15M
Total Long-Term Liabilities $4.127M $212.0K $1.411M
Total Liabilities $7.302M $19.90M $17.73M
YoY Change -58.6% 12.23% -13.98%
SHAREHOLDERS EQUITY
Retained Earnings -$10.85M -$219.6M -$194.1M
YoY Change -94.92% 13.15% 9.34%
Common Stock $4.000K $241.0K $139.0K
YoY Change -97.12% 73.38% 90.41%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$6.460M -$17.82M $6.717M
YoY Change
Total Liabilities & Shareholders Equity $842.0K $2.078M $24.45M
YoY Change -82.52% -91.5% -20.74%

Cashflow Statement

Concept 2016 Q4 2016 Q3 2015 Q3
OPERATING ACTIVITIES
Net Income -$1.430M -$499.0K -$7.299M
YoY Change -92.61% -93.16% 9023.75%
Depreciation, Depletion And Amortization $160.0K $100.0K $100.0K
YoY Change 6.67% 0.0% -83.02%
Cash From Operating Activities -$2.910M -$250.0K -$3.430M
YoY Change -1.02% -92.71% -13.16%
INVESTING ACTIVITIES
Capital Expenditures -$20.00K -$90.00K
YoY Change -125.0% 800.0%
Acquisitions
YoY Change
Other Investing Activities $1.030M $0.00 $1.950M
YoY Change 1044.44% -100.0% -46.58%
Cash From Investing Activities $1.010M $0.00 $1.860M
YoY Change 494.12% -100.0% -48.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.730M 130.0K 2.040M
YoY Change -93.63% 20300.0%
NET CHANGE
Cash From Operating Activities -2.910M -250.0K -3.430M
Cash From Investing Activities 1.010M 0.000 1.860M
Cash From Financing Activities 1.730M 130.0K 2.040M
Net Change In Cash -170.0K -120.0K 470.0K
YoY Change -93.86% -125.53% -256.67%
FREE CASH FLOW
Cash From Operating Activities -$2.910M -$250.0K -$3.430M
Capital Expenditures -$20.00K -$90.00K
Free Cash Flow -$2.890M -$3.340M
YoY Change -4.3% -15.23%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
dei Document Period End Date
DocumentPeriodEndDate
2016-09-30
dei Entity Central Index Key
EntityCentralIndexKey
0001043961
CY2016Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
24786244 shares
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Entity Registrant Name
EntityRegistrantName
TRANSGENOMIC INC
tbio Accounts Receivable General Payment Terms1
AccountsReceivableGeneralPaymentTerms1
P30D
tbio Class Of Warrant Or Right Number Of Issued Warrants Or Rights
ClassOfWarrantOrRightNumberOfIssuedWarrantsOrRights
3466841 shares
tbio Class Of Warrant Or Right Number Of Issued Warrants Or Rights
ClassOfWarrantOrRightNumberOfIssuedWarrantsOrRights
3055555 shares
CY2015Q4 tbio Dividends Preferred Stock Cash Not Declared
DividendsPreferredStockCashNotDeclared
4400000 USD
CY2016Q3 tbio Dividends Preferred Stock Cash Not Declared
DividendsPreferredStockCashNotDeclared
0 USD
tbio Fair Value Assumptions Percentage Of Simulated Equity Values Below Down Round Financing Cut Off Point
FairValueAssumptionsPercentageOfSimulatedEquityValuesBelowDownRoundFinancingCutOffPoint
1
CY2016Q3 tbio Finite Lived Intangible Assets Amortization Expense Current Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseCurrentFiscalYear
100000 USD
CY2015Q4 tbio Furniture Fixtures And Leasehold Improvements Gross
FurnitureFixturesAndLeaseholdImprovementsGross
1565000 USD
CY2016Q3 tbio Furniture Fixtures And Leasehold Improvements Gross
FurnitureFixturesAndLeaseholdImprovementsGross
1565000 USD
CY2015Q3 tbio Gain Loss On Stock Warrants Revaluation
GainLossOnStockWarrantsRevaluation
385000 USD
tbio Gain Loss On Stock Warrants Revaluation
GainLossOnStockWarrantsRevaluation
-30000 USD
CY2016Q3 tbio Gain Loss On Stock Warrants Revaluation
GainLossOnStockWarrantsRevaluation
12000 USD
tbio Gain Loss On Stock Warrants Revaluation
GainLossOnStockWarrantsRevaluation
357000 USD
CY2015Q3 tbio Interest Income And Expense Net
InterestIncomeAndExpenseNet
-174000 USD
tbio Interest Income And Expense Net
InterestIncomeAndExpenseNet
-550000 USD
CY2016Q3 tbio Interest Income And Expense Net
InterestIncomeAndExpenseNet
-285000 USD
tbio Interest Income And Expense Net
InterestIncomeAndExpenseNet
-782000 USD
CY2015Q3 tbio Inventory Additions
InventoryAdditions
0 USD
tbio Inventory Additions
InventoryAdditions
0 USD
CY2016Q3 tbio Inventory Additions
InventoryAdditions
0 USD
tbio Inventory Additions
InventoryAdditions
0 USD
CY2015Q3 tbio Other Income Expense
OtherIncomeExpense
205000 USD
tbio Other Income Expense
OtherIncomeExpense
-599000 USD
CY2016Q3 tbio Other Income Expense
OtherIncomeExpense
-274000 USD
tbio Other Income Expense
OtherIncomeExpense
-426000 USD
CY2015Q3 tbio Provisionfor Doubtful Accounts Excluding Amounts Not Includedin Provision
ProvisionforDoubtfulAccountsExcludingAmountsNotIncludedinProvision
50000 USD
tbio Provisionfor Doubtful Accounts Excluding Amounts Not Includedin Provision
ProvisionforDoubtfulAccountsExcludingAmountsNotIncludedinProvision
50000 USD
CY2016Q3 tbio Provisionfor Doubtful Accounts Excluding Amounts Not Includedin Provision
ProvisionforDoubtfulAccountsExcludingAmountsNotIncludedinProvision
2000 USD
tbio Provisionfor Doubtful Accounts Excluding Amounts Not Includedin Provision
ProvisionforDoubtfulAccountsExcludingAmountsNotIncludedinProvision
72000 USD
CY2016Q3 tbio Working Capital Deficiency
WorkingCapitalDeficiency
-17400000 USD
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3781000 USD
CY2016Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
6273000 USD
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
264000 USD
CY2016Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
180000 USD
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3734000 USD
CY2016Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2704000 USD
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6899000 USD
CY2016Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6985000 USD
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
10000 USD
CY2016Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
0 USD
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
200403000 USD
CY2016Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
201522000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
140000 USD
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
20000 USD
CY2015Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
20000 USD
CY2015Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
70000 USD
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
87000 USD
CY2016Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
157000 USD
CY2016Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
140000 USD
CY2015Q3 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0 USD
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0 USD
CY2016Q3 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
19000 USD
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
19000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
100000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
200000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10392728 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10701453 shares
CY2015Q4 us-gaap Assets
Assets
4816000 USD
CY2016Q3 us-gaap Assets
Assets
2078000 USD
CY2015Q4 us-gaap Assets Current
AssetsCurrent
3282000 USD
CY2016Q3 us-gaap Assets Current
AssetsCurrent
866000 USD
CY2015Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
1987000 USD
CY2016Q3 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
265000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1609000 USD
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2787000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
444000 USD
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
71000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1178000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-373000 USD
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
1910000 USD
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
1052000 USD
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-3010000 USD
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
381000 USD
CY2016Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
8976354 shares
CY2016Q1 us-gaap Common Stock Dividends Shares
CommonStockDividendsShares
4474825 shares
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2016Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13915691 shares
CY2016Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24139130 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13915691 shares
CY2016Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24139130 shares
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
139000 USD
CY2016Q3 us-gaap Common Stock Value
CommonStockValue
241000 USD
CY2015Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7321000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13629000 USD
CY2016Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1926000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6187000 USD
CY2015Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
445000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1375000 USD
CY2016Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
430000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1477000 USD
CY2015Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
7596000 USD
CY2016Q3 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
7814000 USD
CY2016Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
176000 USD
CY2015Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
217000 USD
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
321000 USD
CY2015Q3 us-gaap Depreciation
Depreciation
100000 USD
us-gaap Depreciation
Depreciation
200000 USD
CY2016Q3 us-gaap Depreciation
Depreciation
100000 USD
us-gaap Depreciation
Depreciation
100000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
343000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
264000 USD
us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
4475000 USD
CY2015Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.55
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.24
CY2016Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.28
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
2000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
0 USD
CY2016Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
225000 USD
CY2016Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
100000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
30000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-357000 USD
CY2015Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
481000 USD
CY2016Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
370000 USD
CY2016Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
100000 USD
CY2016Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
100000 USD
CY2016Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
100000 USD
CY2016Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
100000 USD
CY2015Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1651000 USD
CY2016Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1352000 USD
CY2015Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1170000 USD
CY2016Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
982000 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-14000 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0 USD
CY2015Q3 us-gaap Gross Profit
GrossProfit
-115000 USD
us-gaap Gross Profit
GrossProfit
147000 USD
CY2016Q3 us-gaap Gross Profit
GrossProfit
27000 USD
us-gaap Gross Profit
GrossProfit
-279000 USD
CY2015Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-2051000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-7223000 USD
CY2016Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-1892000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-6162000 USD
CY2015Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2051000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7224000 USD
CY2016Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1892000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6162000 USD
CY2015Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-5248000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-6392000 USD
CY2016Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-34000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-25000 USD
CY2015Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1000 USD
CY2016Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2016Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2015Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-162000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2492000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-158000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-12000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
0 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
0 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
61000 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
47000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
0 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-14000 USD
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
78000 USD
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-728000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
214000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-280000 USD
CY2015Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1170000 USD
CY2016Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
982000 USD
us-gaap Interest Paid
InterestPaid
365000 USD
us-gaap Interest Paid
InterestPaid
0 USD
CY2015Q4 us-gaap Inventory Net
InventoryNet
50000 USD
CY2016Q3 us-gaap Inventory Net
InventoryNet
36000 USD
CY2016Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
100000 USD
CY2014Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0 USD
CY2015Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0 USD
CY2015Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0 USD
CY2015Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
63000 USD
CY2016Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
63000 USD
CY2016Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
63000 USD
CY2015Q3 us-gaap Inventory Write Down
InventoryWriteDown
0 USD
us-gaap Inventory Write Down
InventoryWriteDown
0 USD
CY2016Q3 us-gaap Inventory Write Down
InventoryWriteDown
0 USD
us-gaap Inventory Write Down
InventoryWriteDown
0 USD
CY2015Q4 us-gaap Liabilities
Liabilities
17636000 USD
CY2016Q3 us-gaap Liabilities
Liabilities
19902000 USD
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4816000 USD
CY2016Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2078000 USD
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
16981000 USD
CY2016Q3 us-gaap Liabilities Current
LiabilitiesCurrent
18260000 USD
CY2015Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
264000 USD
CY2016Q3 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
0 USD
CY2015Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
7596000 USD
CY2016Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
7814000 USD
CY2015Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0 USD
CY2016Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0 USD
CY2015Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
5593000 USD
CY2016Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
5592000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8991000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-289000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-46000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9436000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3574000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-6426000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-3955000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2195000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1621000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1006000 USD
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-7299000 USD
us-gaap Net Income Loss
NetIncomeLoss
-13615000 USD
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
-1926000 USD
us-gaap Net Income Loss
NetIncomeLoss
-6187000 USD
CY2015Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7630000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-14608000 USD
CY2016Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1926000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6208000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2015Q3 us-gaap Operating Expenses
OperatingExpenses
2141000 USD
us-gaap Operating Expenses
OperatingExpenses
6772000 USD
CY2016Q3 us-gaap Operating Expenses
OperatingExpenses
1645000 USD
us-gaap Operating Expenses
OperatingExpenses
5457000 USD
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2256000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-6625000 USD
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1618000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-5736000 USD
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
700000 USD
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
700000 USD
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
700000 USD
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
700000 USD
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
400000 USD
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
200000 USD
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
200000 USD
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
200000 USD
CY2015Q4 us-gaap Other Assets Current
OtherAssetsCurrent
537000 USD
CY2016Q3 us-gaap Other Assets Current
OtherAssetsCurrent
314000 USD
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
105000 USD
CY2016Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
58000 USD
CY2015Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-22000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-14000 USD
CY2016Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0 USD
CY2015Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1068000 USD
CY2016Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1068000 USD
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
305000 USD
CY2016Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
212000 USD
CY2015Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-6000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-19000 USD
CY2016Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1000 USD
CY2016Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
200000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
9000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
27000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
280000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
19000 USD
CY2015Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
331000 USD
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
993000 USD
CY2016Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
0 USD
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
21000 USD
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2016Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000 shares
CY2016Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000 shares
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
4029502 shares
CY2016Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
214705 shares
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
4029502 shares
CY2016Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
214705 shares
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
40000 USD
CY2016Q3 us-gaap Preferred Stock Value
PreferredStockValue
2000 USD
CY2016Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
100000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
8977000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
468000 USD
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
0 USD
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
1779000 USD
CY2015Q3 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
3000000 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
923000 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
500000 USD
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7158000 USD
CY2016Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7157000 USD
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
259000 USD
CY2016Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
172000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
72000 USD
CY2016Q3 us-gaap Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
100000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
35000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
2000 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
874000 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
550000 USD
CY2015Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
455000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1374000 USD
CY2016Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
393000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1065000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5398000 USD
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-213412000 USD
CY2016Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-219589000 USD
CY2015Q3 us-gaap Sales Revenue Net
SalesRevenueNet
330000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
1522000 USD
CY2016Q3 us-gaap Sales Revenue Net
SalesRevenueNet
457000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
1198000 USD
CY2015Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1686000 USD
CY2016Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1252000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4392000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
489000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
111000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P1Y1M1D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.85
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0156
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
641560 shares
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
11250 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
25250 shares
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
0 USD
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
860411 shares
CY2015Q3 us-gaap Share Price
SharePrice
1.42
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y0M0D
CY2015Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1500000 shares
CY2016Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
6780179 shares
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
4475000 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
500000 USD
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
-12820000 USD
CY2016Q3 us-gaap Stockholders Equity
StockholdersEquity
-17824000 USD
CY2015Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
350000 USD
CY2016Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
1430000 USD
CY2015Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
13763240 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
11784583 shares
CY2016Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
23551869 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
21896943 shares
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain prior year amounts have been reclassified to conform to the current year presentation in our condensed consolidated financial statements, which consists of the effects of reclassifications from the presentation of our discontinued operations.</font></div></div>
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of condensed consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of net sales and expenses during the reporting period. In addition, estimates and assumptions associated with the determination of the fair value of certain assets and related impairments require considerable judgment by management. Actual results could differ from the estimates and assumptions used in preparing these condensed consolidated financial statements.</font></div></div>

Files In Submission

Name View Source Status
0001043961-16-000037-index-headers.html Edgar Link pending
0001043961-16-000037-index.html Edgar Link pending
0001043961-16-000037.txt Edgar Link pending
0001043961-16-000037-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tbio-20160930.xml Edgar Link completed
tbio-20160930.xsd Edgar Link pending
tbio-20160930x10q.htm Edgar Link pending
tbio-20160930_cal.xml Edgar Link unprocessable
tbio-20160930_def.xml Edgar Link unprocessable
tbio-20160930_lab.xml Edgar Link unprocessable
tbio-20160930_pre.xml Edgar Link unprocessable
tbio-ex311_20160930x10q.htm Edgar Link pending
tbio-ex31_20160930x10q.htm Edgar Link pending
tbio-ex321_20160930x10q.htm Edgar Link pending